Hollysys (HOLI) Moves Higher Following High-Speed Rail Supply Contract in China
Tweet Send to a FriendGet Alerts HOLI Hot Sheet
Up)
Trade HOLI Now!
Hollysys Automation Technologies, Ltd. (Nasdaq: HOLI) is gapping higher Monday after announcing a new contract win in China. Shares are up 3.5 percent on the session.
From the release:
"[Hollysys] signed a contract to supply its ground-based high-speed rail signaling system to Xi'an-Baoji high-speed rail line with a designed traveling speed of 300-350 km/h and 138km in total length. The whole contract is valued at approximately US $8.86 million or RMB 56 million.
Pursuant to the terms of the contract, Hollysys will supply its ground-based high-speed rail signaling system, including Train Control Center (TCC), Radio Block Center (RBC) and other auxiliary equipments, which are expected to be delivered and installed by May 2013."
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
From the release:
"[Hollysys] signed a contract to supply its ground-based high-speed rail signaling system to Xi'an-Baoji high-speed rail line with a designed traveling speed of 300-350 km/h and 138km in total length. The whole contract is valued at approximately US $8.86 million or RMB 56 million.
Pursuant to the terms of the contract, Hollysys will supply its ground-based high-speed rail signaling system, including Train Control Center (TCC), Radio Block Center (RBC) and other auxiliary equipments, which are expected to be delivered and installed by May 2013."
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Senate Takes Aim at Apple (AAPL); Says Irish Unit Earned $22B, Paid $10M in Taxes
- Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
- Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
Create E-mail Alert Related Categories
Corporate News
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
